B-313 Assessment of β2-microglobulin concentration in pleural effusions

S Bérgamo Vázquez,J Trapé Pujol,J Rives Jimenez,C González Fernández,L González García
DOI: https://doi.org/10.1093/clinchem/hvae106.670
IF: 12.114
2024-10-27
Clinical Chemistry
Abstract:Backgroundβ2-microglobulin (β2-m) is a biomarker used in serum for different types of pathologies. It has been described that lymphocyte activation processes us tuberculosis infections, AIDS virus or cytomegalovirus infections, can produce an increase in the concentration of this marker. As a tumor marker is useful in lymphomas diagnosis. In the bibliography has reported that processes involving renal failure lead to a significant increase in its concentration. In patients with renal failure and treated with hemodialysis, have been described medians twenty times the upper reference limit. The objective is to assess whether the concentration of (β2-m) in pleural fluid is affected by the same factors as in serum.MethodsWe analyzed 303 pleural effusions (PE) samples from undiagnosed patients with pleural effusion. β2-microglobulin levels were prospectively measured by electrochemiluminescence (ECLIA) assays (Cobas c702, Roche Diagnostics®). Glomerular filtration rate (GFR) was calculated by CKD-EPI equation. The diagnostic performance of β2-microglobulin was evaluated by receiver operating characteristic (ROC) curve analysis. Statistical analyses were performed using SPSS software.ResultsPleural fluid of 303 patients (104 female, 204 male) were collected. The median age was 72 ± 10,6 years. For all samples β2-m median concentration was 5,85 mg/L (IQR:3.4 -6.45).When we compared all results according to kidney failure values; GFR >60mL/min β2-m median concentration was 4,12mg/L and if GFR <60 mL/min, β2-m was 8,62g/L significant difference have found (p<0,001). Comparing results between malignant pleural effusions (MPE) (n=96) and benign pleural effusions (BPE) (n=207), MPE median concentration was 5.38 mg/L and 6.07mg/L significant difference (p 60 mL/min), the area under the ROC curve was 0.98 (95% CI: 0.88-0.98) (p 60 mL/min and tuberculosis. Using 5,15 mg/L cut-off point, 100% of NPV was obtained.
medical laboratory technology
What problem does this paper attempt to address?